Free Trial

Hood River Capital Management LLC Raises Stake in Select Medical Holdings Co. (NYSE:SEM)

Select Medical logo with Medical background

Hood River Capital Management LLC raised its stake in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 404.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,755,733 shares of the health services provider's stock after buying an additional 1,407,902 shares during the period. Hood River Capital Management LLC owned 1.36% of Select Medical worth $33,096,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. Smartleaf Asset Management LLC raised its holdings in shares of Select Medical by 179.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock worth $43,000 after buying an additional 1,473 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new stake in Select Medical in the third quarter valued at approximately $81,000. Covestor Ltd increased its position in shares of Select Medical by 33.5% during the fourth quarter. Covestor Ltd now owns 4,955 shares of the health services provider's stock worth $93,000 after acquiring an additional 1,244 shares in the last quarter. Virtu Financial LLC acquired a new stake in Select Medical in the 3rd quarter valued at $210,000. Finally, Tidal Investments LLC bought a new position in Select Medical during the third quarter worth about $286,000. Institutional investors own 89.48% of the company's stock.

Select Medical Stock Up 2.8 %

Shares of NYSE:SEM traded up $0.49 during trading on Monday, reaching $17.84. 467,658 shares of the stock were exchanged, compared to its average volume of 824,051. The stock has a fifty day moving average of $17.04 and a two-hundred day moving average of $22.23. Select Medical Holdings Co. has a 1-year low of $14.99 and a 1-year high of $40.98. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The firm has a market cap of $2.30 billion, a price-to-earnings ratio of 10.82, a price-to-earnings-growth ratio of 0.64 and a beta of 1.38.

Select Medical (NYSE:SEM - Get Free Report) last posted its earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.29 by ($0.11). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The business had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.50 billion. Research analysts anticipate that Select Medical Holdings Co. will post 1.17 earnings per share for the current fiscal year.

Select Medical Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 13th. Shareholders of record on Monday, March 3rd were paid a $0.0625 dividend. The ex-dividend date was Monday, March 3rd. This represents a $0.25 annualized dividend and a yield of 1.40%. Select Medical's dividend payout ratio (DPR) is 15.15%.

Wall Street Analysts Forecast Growth

SEM has been the topic of a number of analyst reports. UBS Group reduced their price target on Select Medical from $40.00 to $21.00 and set a "neutral" rating on the stock in a research report on Friday, January 3rd. Mizuho began coverage on Select Medical in a research note on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 price objective for the company. Benchmark upgraded Select Medical from a "hold" rating to a "buy" rating and set a $23.00 target price on the stock in a report on Monday, February 24th. StockNews.com raised shares of Select Medical from a "hold" rating to a "buy" rating in a research note on Friday, February 21st. Finally, Royal Bank of Canada decreased their price target on Select Medical from $47.00 to $23.00 and set an "outperform" rating for the company in a report on Monday, February 24th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, Select Medical has an average rating of "Moderate Buy" and a consensus price target of $26.80.

View Our Latest Research Report on SEM

About Select Medical

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Further Reading

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Should You Invest $1,000 in Select Medical Right Now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines